NIH Outlines New Game Plan to Combat Opioid Crisis NIH Outlines New Game Plan to Combat Opioid Crisis

The HEAL initiative will focus on improving treatments for patients who misuse or are addicted to opioids and enhancing strategies for effective pain management.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Related Links:

Authors: Saloner B, McGinty EE, Beletsky L, Bluthenthal R, Beyrer C, Botticelli M, Sherman SG Abstract Drug overdose is now the leading cause of injury death in the United States. Most overdose fatalities involve opioids, which include prescription medication, heroin, and illicit fentanyl. Current data reveal that the overdose crisis affects all demographic groups and that overdose rates are now rising most rapidly among African Americans. We provide a public health perspective that can be used to mobilize a comprehensive local, state, and national response to the opioid crisis. We argue that framing the crisis fro...
Source: Public Health Reports - Category: International Medicine & Public Health Tags: Public Health Rep Source Type: research
The American Medical Association (AMA) has pushed back against the movement to arbitrarily restrict opioids for pain management. The AMA's House of Delegates last week approved a resolution that praised the federal Centers for Disease Control and Prevention (CDC) for “its efforts to prevent incidence of new cases of opioid misuse, addiction, and overdose deaths,” but also urged the AMA to argue against putting blanket limits on the amount and dosage of opioids that physicians can prescribe. “This is a recognition that there are many patients we deal with d aily who are outside the norms proffered by the C...
Source: Alcoholism and Drug Abuse Weekly - Category: Addiction Tags: Briefly Noted Source Type: research
Abbott (NYSE:ABT) said today that it won FDA clearance and CE Mark approval in the European Union for its DRG Invisible Trial System intended to allow patients with complex chronic pain conditions to receive a trial treatment with the company’s dorsal root ganglion stimulation system. Abbott’s DRG therapy targets the dorsal root ganglion, a structure adjacent to the spinal cord populated with nerves that transmit chronic pain to the central nervous system. The therapy is intended to aid people living with neuropathic pain conditions by blocking pain signals with electrical pulses transmitted over the ...
Source: Mass Device - Category: Medical Devices Authors: Tags: 510(k) Food & Drug Administration (FDA) Neuromodulation/Neurostimulation Pain Management Regulatory/Compliance Abbott Source Type: news
Body contouring procedure is a catchall that includes mastopexy, abdominoplasty, liposuction, and lower body lift. It is well known that optimal postoperative pain control decreases hospitalization length of stay and promotes early ambulation, which in turn decreases the incidence of complications. There have been many innovations in pain control beyond opiate medications, including prolonged administration of local anesthesia, regional blocks, and the use of a multimodal regimen which utilizes nonopiates. All approaches aim to decrease oral or intravenous opiate use and, therefore, encourage faster return to normal bowel ...
Source: Clinics in Plastic Surgery - Category: Cosmetic Surgery Authors: Source Type: research
facilitate the identification of novel non-opioid natural products with efficacious and non-addictive analgesic properties. The workshop will also discuss research barriers for the study of such natural products for pain treatment and management. We hope that through this workshop we will provide novel and important contributions to the goal of finding solutions to the current pain and opioid crisis.Air date: 2/6/2019 8:30:00 AM
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
Conclusion Evidence of clinical benefit of most available apps is very limited. Design features that enhance usability and maximise efficacy were identified. A provisional 'first-pass' evaluation framework is proposed that can help decide which apps should be endorsed by government agencies following more detailed technical assessments and which could then be recommended with confidence by clinicians to their patients.What is known about the topic? Smartphone health apps have attracted considerable interest from patients and health managers as a means of promoting more effective self-management of chronic diseases, which l...
Source: Australian Health Review - Category: Hospital Management Authors: Tags: Aust Health Rev Source Type: research
Abstract Drug overdose deaths involving opioids have surged in recent years and the economic cost of the opioid epidemic is estimated to be over $500 billion annually. In the midst of calls for declaring a national emergency, health policy decision makers are considering the best ways to allocate resources to curb the epidemic. On June 9, 2017, 116 invited health researchers, clinicians, policymakers, health system leaders, and other stakeholders met at the University of Pennsylvania to discuss approaches to address the gaps in evidence-based substance use disorder policy and practice, with an emphasis on the opio...
Source: Addiction Science and Clinical Practice - Category: Addiction Authors: Tags: Addict Sci Clin Pract Source Type: research
Much of what we think we know about cannabis may soon change as a result of new research that uncovers some surprising facts. Indeed, the topic, which can be emotionally charged, is the focus of intense scientific study. Is cannabis good for you? Is it addictive? What long-term harms can use cause? The answers to these questions are multi-layered and not always clear-cut, which is why cannabis research continues with even more urgency. FACTS ON CANNABIS ADDICTION AND DEPENDENCE Current estimates are that one in 10 cannabis users will develop cannabis addiction or dependence. The potency of the delta-9-tetrahydrocannabinol ...
Source: Psych Central - Category: Psychiatry Authors: Tags: Addictions Habits Healthy Living Memory and Perception Miscellaneous Drugs Neuroscience Substance Abuse Source Type: news
On November 2 the Food and Drug Administration  announced the approval of Dsuvia, a sublingual tablet containing the powerful fentanyl analog, sufentanil. Sufentanil has been used for years in the hospital setting, primarily in intravenous form for anesthesia. It is  roughly 5 to 10 times more potent than fentanyl, and thus has a significant overdose potential. The FDA reached this decision following a 10-3 vote in favor of the drug’s approval by the Anesthetic and Analgesia Drug Products Advisory Committee (AADPAC),based on data from multicenter trials.  It was not approved for outpatie...
Source: Cato-at-liberty - Category: American Health Authors: Source Type: blogs
Ethimedix, a Swiss medical device company, has developed the SmartBottle, a drug administration device for analgesics. The device is a programmable “lockbox” which allows for the controlled administration of single doses of opioid painkil...
Source: Medgadget - Category: Medical Devices Authors: Tags: Exclusive Geriatrics Medicine Pain Management Source Type: blogs
More News: Addiction | Brain | Health | Neurology | Neurosurgery | Pain | Pain Management